At the time of writing, Sana Biotechnology Inc [SANA] stock is trading at $4.58, up 0.44%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SANA shares have gain 12.81% over the last week, with a monthly amount drifted -7.29%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on September 24, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $5. On March 18, 2025, upgrade upgraded it’s rating to Mkt Outperform but maintained its price target of $5 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $7 on March 14, 2025. TD Cowen upgraded its rating to a Buy. JMP Securities downgraded its rating to Mkt Perform for this stock on November 05, 2024. In a note dated June 26, 2024, Rodman & Renshaw initiated a Buy rating and provided a target price of $16 on this stock.
For the past year, the stock price of Sana Biotechnology Inc fluctuated between $1.26 and $6.55. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $4.58 at the most recent close of the market. An investor can expect a potential return of 74.67% based on the average SANA price forecast.
Analyzing the SANA fundamentals
Gross Profit Margin for this corporation currently stands at -0.19% with Operating Profit Margin at -16.9%, Pretax Profit Margin comes in at -16.5%, and Net Profit Margin reading is -16.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.7, Equity is -1.15 and Total Capital is -0.79. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Sana Biotechnology Inc [NASDAQ:SANA] has a current ratio of 4.55. In addition, the Quick Ratio stands at 4.55 and the Cash Ratio stands at 2.13.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Feb 18 ’25 when 75000.0 shares were purchased. Officer, CHRISTIAN HORDO & KATHARINE HO completed a deal on Jan 16 ’25 to buy 75000.0 shares.
